Team Felbermayr - Simplon Wels
.jpg) |
|
| Team information | |
|---|---|
| UCI code | RSW |
| Registered | Austria |
| Founded | 2004 |
| Discipline | Road |
| Status | UCI Continental |
| Key personnel | |
| Team manager(s) | Andreas Grossek |
| Team name history | |
| 2004 2005 2006 2007 2008–2009 2010–2011 2012 2013 2014 2015– |
Radclub–Resch & Frisch–EYBL Arbö–Resch & Frisch–EYBL RC Arbö–Resch & Frisch–Wels RC Arbö–Resch & Frisch–Gourmetfein–Wels RC Arbö–Wels–Gourmetfein RC Arbö–Gourmetfein–Wels RC Arbö–Wels–Gourmetfein Gourmetfein–Simplon Gourmetfein–Simplon Wels Felbermayr–Simplon Wels |
Felbermayr–Simplon Wels (UCI team code: RSW) is a UCI Continental team founded in 2004. It is based in Austria and it participates in UCI Continental Circuits races.
In July 2017, it was announced by the UCI that Matija Kvasina had tested positive for an experimental drug known as Molidustat (BAY-85-3934), during two tests taken during the 2017 Fleche du Sud - a race in which he won. Molidustat represents a class of drugs that act on the same physiological pathways and enzyme cascades as those which are activated during altitude training. Oxygen deprivation has the effect of stimulating the body's production of erythropoeitin (EPO) - Molidustat imitates this. Kvasina was subsequently kicked out of the 2017 Tour of Austria.
...
Wikipedia